Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Atherosclerosis imaging and circulating blood biomarkers: insights into subclinical atherosclerotic plaque burden and disease activity.

Schoenhagen P.

Int J Cardiovasc Imaging. 2005 Aug;21(4):443-5. No abstract available.

PMID:
16047126
2.

Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.

Van Mieghem CA, Bruining N, Schaar JA, McFadden E, Mollet N, Cademartiri F, Mastik F, Ligthart JM, Granillo GA, Valgimigli M, Sianos G, van der Giessen WJ, Backx B, Morel MA, Van Es GA, Sawyer JD, Kaplow J, Zalewski A, van der Steen AF, de Feyter P, Serruys PW.

Int J Cardiovasc Imaging. 2005 Aug;21(4):425-41.

PMID:
16047125
3.

The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.

Momiyama Y, Ohmori R, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Nagata M, Ohsuzu F.

Atherosclerosis. 2012 Jun;222(2):577-80. doi: 10.1016/j.atherosclerosis.2012.03.023. Epub 2012 Apr 2. No abstract available.

PMID:
22516791
4.

Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.

Nasu K, Terashima M, Habara M, Ko E, Ito T, Yokota D, Ishizuka S, Kurita T, Kimura M, Kinoshita Y, Asakura Y, Tsuchikane E, Katoh O, Suzuki T.

JACC Cardiovasc Interv. 2013 Jul;6(7):746-55. doi: 10.1016/j.jcin.2013.02.018. Epub 2013 Jun 14.

5.

Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins.

Ferrières J.

Am J Cardiovasc Drugs. 2009;9(2):109-15. doi: 10.2165/00129784-200909020-00005. Review.

PMID:
19331439
6.

The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.

Takarada S, Imanishi T, Ishibashi K, Tanimoto T, Komukai K, Ino Y, Kitabata H, Kubo T, Tanaka A, Kimura K, Mizukoshi M, Akasaka T.

JACC Cardiovasc Interv. 2010 Jul;3(7):766-72. doi: 10.1016/j.jcin.2010.05.001.

7.

Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.

Koskinas KC, Zaugg S, Yamaji K, García-García HM, Taniwaki M, Klingenberg R, Moschovitis A, Lüscher TF, van Tits LJ, Matter CM, Windecker S, Räber L.

Atherosclerosis. 2016 Apr;247:154-60. doi: 10.1016/j.atherosclerosis.2016.02.015. Epub 2016 Feb 16.

PMID:
26921743
8.

Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.

Voros S, Joshi P, Qian Z, Rinehart S, Vazquez-Figueroa JG, Anderson H, Elashoff M, Murrieta L, Karmpaliotis D, Kalynych A, Brown C 3rd, Schaefer E, Asztalos B.

J Am Heart Assoc. 2013 Nov 19;2(6):e000344. doi: 10.1161/JAHA.113.000344.

9.
10.

The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.

Puri R, Nissen SE, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nicholls SJ.

Eur J Prev Cardiol. 2016 Mar;23(5):474-85. doi: 10.1177/2047487315572920. Epub 2015 Feb 17.

PMID:
25691546
11.

Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet.

Koh KK, Son JW, Ahn JY, Choi YM, Jin DK, Park GS, Choi IS, Sohn MS, Shin EK.

Coron Artery Dis. 2001 Jun;12(4):305-11.

PMID:
11428539
12.

Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study.

Bahrami H, Budoff M, Haberlen SA, Rezaeian P, Ketlogetswe K, Tracy R, Palella F, Witt MD, McConnell MV, Kingsley L, Post WS.

J Am Heart Assoc. 2016 Jun 27;5(6). pii: e003371. doi: 10.1161/JAHA.116.003371.

13.

Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease.

Wang X, Zhao X, Li L, Yao H, Jiang Y, Zhang J.

Heart Lung Circ. 2016 May;25(5):459-65. doi: 10.1016/j.hlc.2015.10.012. Epub 2015 Nov 18.

PMID:
26687339
14.

HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain.

Caselli C, De Graaf MA, Lorenzoni V, Rovai D, Marinelli M, Del Ry S, Giannessi D, Bax JJ, Neglia D, Scholte AJ.

Atherosclerosis. 2015 Jul;241(1):55-61. doi: 10.1016/j.atherosclerosis.2015.04.811. Epub 2015 May 1.

PMID:
25966440
15.

Can an intravascular imaging modality detect really vulnerable plaque?

Takayama T.

Circ J. 2010 Feb;74(2):252-3. Epub 2010 Jan 9. No abstract available.

16.

MMP-1 serum levels predict coronary atherosclerosis in humans.

Lehrke M, Greif M, Broedl UC, Lebherz C, Laubender RP, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Göke B, Steinbeck G, Leber AW, Parhofer KG.

Cardiovasc Diabetol. 2009 Sep 14;8:50. doi: 10.1186/1475-2840-8-50.

17.

A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?

Wen J, Wen Y, Zhiliang L, Lingling C, Longxing C, Ming W, Qiang F.

Heart Vessels. 2013 Mar;28(2):135-42. doi: 10.1007/s00380-011-0218-1. Epub 2012 Jan 7.

PMID:
22227998
18.

Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography.

Buljubasic N, Akkerhuis KM, Cheng JM, Oemrawsingh RM, Garcia-Garcia HM, de Boer SP, Regar E, van Geuns RM, Serruys PW, Boersma E, Kardys I.

Coron Artery Dis. 2017 Jan;28(1):23-32.

19.

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA.

J Am Coll Cardiol. 2004 Nov 2;44(9):1812-8.

20.

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.

Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ.

Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):380-8. doi: 10.1093/ehjci/jet251. Epub 2014 Jan 20.

PMID:
24448227

Supplemental Content

Support Center